Cargando…
Low-Molecular-Weight Heparin or Dual Antiplatelet Therapy Is More Effective Than Aspirin Alone in Preventing Early Neurological Deterioration and Improving the 6-Month Outcome in Ischemic Stroke Patients
BACKGROUND AND PURPOSE: Dual antiplatelet therapy (DAT) with clopidogrel and aspirin has been shown to confer greater protection against early neurological deterioration (END) and early recurrent ischemic stroke (ERIS) than aspirin alone in patients who have experienced an acute ischemic stroke. How...
Autores principales: | Yi, Xingyang, Chi, Wanzhang, Wang, Chun, Zhang, Biao, Lin, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302180/ https://www.ncbi.nlm.nih.gov/pubmed/25628738 http://dx.doi.org/10.3988/jcn.2015.11.1.57 |
Ejemplares similares
-
Effect of Argatroban Combined With Dual Antiplatelet Therapy on Early Neurological Deterioration in Acute Minor Posterior Circulation Ischemic Stroke
por: Zhou, Ling-Shan, et al.
Publicado: (2020) -
Response to clopidogrel is associated with early neurological deterioration after acute ischemic stroke
por: Yi, Xingyang, et al.
Publicado: (2018) -
Platelet function-guided modification in antiplatelet therapy after acute ischemic stroke is associated with clinical outcomes in patients with aspirin nonresponse
por: Yi, Xingyang, et al.
Publicado: (2017) -
Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel
por: Yi, Xingyang, et al.
Publicado: (2020) -
Interaction among COX-2, P2Y1 and GPIIIa gene variants is associated with aspirin resistance and early neurological deterioration in Chinese stroke patients
por: Yi, Xingyang, et al.
Publicado: (2017)